S'abonner

Utility of specific laboratory biomarkers to predict severe sepsis in pediatric patients with SIRS - 30/11/21

Doi : 10.1016/j.ajem.2021.09.081 
Shannon Byler, MD, MPH a, , Alexandra Baker, MD b, c, Eli Freiman, MD b, c, Joshua C. Herigon, MD, MPH, MBI c, d, Matthew A. Eisenberg, MD, MPH b, c
a Boston Combined Residency Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States of America 
b Division of Emergency Medicine, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States of America 
c Department of Pediatrics, Harvard Medical School, Boston, MA, United States of America 
d Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States of America 

Corresponding author at: Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States of America.Boston Children's Hospital300 Longwood AveBostonMA02115United States of America

Abstract

Objective

To identify the association between readily available laboratory biomarkers and the development of severe sepsis in children presenting to the emergency department (ED) with systemic inflammatory response syndrome (SIRS).

Methods

In this retrospective cohort study, ED patient encounters from June 2018 to June 2019 that triggered an automated sepsis alert based on SIRS criteria were analyzed. Encounters were included if the patient had any of the following laboratory tests sent within 6 h of ED arrival: C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), lactic acid, and procalcitonin. For each of the biomarkers, a receiver operating characteristic (ROC) curve was created for our primary outcome, severe sepsis within 24 h of ED disposition, and our secondary outcome, severe sepsis with a positive bacterial culture. For each ROC curve, we calculated the area under the curve (AUC) with 95% confidence intervals (95% CI) and created cutoff points to achieve 90% sensitivity and 90% sensitivity for the primary and secondary outcomes.

Results

During the study period, 4349/61,195 (7.1%) encounters triggered an automated sepsis alert. Of those, 1207/4349 (27.8%) had one of the candidate biomarkers sent within 6 h of ED arrival and were included in the study. A total of 100/1207 (8.3%) met criteria for severe sepsis within 24 h of arrival, and 41/100 severe sepsis cases (41%) were deemed culture-positive. Procalcitonin had the highest AUC for identifying severe sepsis [0.62 (95% CI 0.52–0.73)] while ESR and CRP had the highest AUC for culture-positive sepsis [0.68 (95% CI 0.47–0.89) and 0.67 (95% CI 0.53–0.81), respectively]. At 90% sensitivity for detecting severe sepsis, all of the biomarker threshold values fell within that laboratory test's normal range. At 90% specificity for severe sepsis, threshold values were as follows: procalcitonin 2.72 ng/mL, CRP 16.79 mg/dL, ESR 79.5 mm/h and lactic acid 3.6 mmol/L.

Conclusion

Our data indicate that CRP, ESR, lactic acid, and procalcitonin elevations were all specific, but not sensitive, in identifying children in the ED with SIRS who go on to develop severe sepsis.

Le texte complet de cet article est disponible en PDF.

Highlights

Marked elevation of biomarkers can help differentiate SIRS from sepsis.
Elevations were specific, but not sensitive, in identifying children with sepsis.
Procalcitonin had the highest AUC of all biomarkers for identifying all-cause sepsis.
ESR and CRP outperformed other biomarkers in identifying culture positive sepsis.

Le texte complet de cet article est disponible en PDF.

Keywords : Biomarkers, Pediatric, sepsis, Systemic inflammatory response syndrome


Plan


© 2021  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 50

P. 778-783 - décembre 2021 Retour au numéro
Article précédent Article précédent
  • Early palliative intervention in septic patients reduces healthcare utilization
  • Rita A Manfredi, Jesus Trevino, Florence Yan, Murwarit Rahimi, Evan Shapiro, Pouya Gharehdaghi, Ali Pourmand
| Article suivant Article suivant
  • Evaluation of the ventilatory effects on human subjects in prolonged hip-flexed/head-down restraint position
  • Richard Childers, Alexandrea O. Cronin, Edward M. Castillo, Tom Neuman, Theodore C. Chan, Christopher J. Coyne, Christian Sloane, Gary M. Vilke

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.